Parkinson’s disease is a form of Parkinson’s disease which affects the central nervous system. The disease is a degenerative disorder of the central nervous system characterized by rigidity and tremor of motor skills, followed by loss of muscle coordination and speech problems. Parkinson’s symptoms usually develop gradually and are characterized by involuntary movements of the body. In early Parkinson’s symptoms, the disease has not yet reached the later stages where objective tests can indicate the progress of the disease. The early symptoms may include the characteristic loss of balance and coordination or floppy muscles that clump and droop.
Parkinson’s symptoms gradually worsen with time and can result in rigidity, increasing in the spread of the movement of the body, a bradykinesia (lack of muscle tone), loss of speech and abnormal behavior such as Parkinsonism (irritability, distractibility and increased bradykinesia). When left untreated, Parkinson’s can progress to cause Parkinson’s disease (PD) and later referred to as degeneration of the brain. Symptoms of PD include uncontrolled movements of body (tricyclic movement), rigid facial expression, bradykinesia (loss of muscle tone), depression and irritability.
The first Parkinson’s symptoms appear after the age of 40. These symptoms are divided into motor symptoms (impulsivity, rigidity, slowing of movement) and speech/language symptoms (impairment of language usage). Motor symptoms include uncontrollable muscle movements, for example, shaking, twitching, jerking and limp movements. Speech/language symptoms are also divided into vocalization (irritability, accent changes, slurring) and gestures. People with Parkinson’s often have difficulties with language development, have problems with language organization (difficulties with making specific body movements), and have problems with facial expression and gestures.
The early symptoms of Parkinson’s disease are also seen on one side only – the left side. This condition is called Parkinsonism. It occurs due to dopamine deficiency in the brain. If left untreated, it can progress to become worse. When left untreated, it can eventually lead to bradykinesia (a decrease of muscle tone), which is one of the earliest Parkinson’s symptoms.
In the later stages of Parkinson’s disease (when it has progressed to bradykinesia), involuntary movement of the body (tremor, rigidity, slowing of movement) can be seen on both sides. People with Parkinson’s disease also report a loss of sensation, either sensorial (seeing objects) or olfactory (scented) impulses, and asymmetry in vision (preschoolers have trouble seeing objects at distances they would see clearly at an early age). These symptoms mirror those of tremor, which is another early symptom of Parkinson’s.
Other symptoms include rigidity, and deterioration of muscles at the neck, wrists, and shoulders. Spasticity and atrophy of face, arms, legs, and trunk also occur at the later stages of Parkinson’s disease. Weight loss is common in people diagnosed with Parkinson’s disease. However, despite the loss of body weight, there is still an increase in height and joint hypertrophy.
Because the brain uses dopamine for its own communication system, loss of this important neurotransmitter can have disastrous effects on the brain. This is why it is particularly worrisome that more people are experiencing Parkinson’s symptoms. Dopamine is responsible for coordinating external stimuli such as movement, muscle tension, or mental activity. In the absence of dopamine, communication between the brain and muscles is broken down, causing stiffness, muscle tremors, and loss of coordination.
Because medications can help control these early symptoms of Parkinson’s disease, and because research has shown that medication can improve survival rates for patients who have already reached the later stages of the disease, more people living with Parkinson’s are turning to medications to help control their debilitating symptoms. There are three classes of medications currently available. These include dopamine agonists, inhibitors, and mutagens. Although research is ongoing, for now it is believed that dopamine antagonists are the best hope for Parkinson’s sufferers.
Oren Zarif – Psychokinesis Treatment
